Evidence in Digital Therapeutics – Proof and Power

The key differentiator between ‘digital health and wellbeing technologies’ and ‘digital therapeutics’ is that the latter must show improved outcomes. Approximately 140 studies were published in 2017 which contained clinical evidence of digital health efficacy [1]. Clinically validated technologies have looked to show value for health systems by reducing emergency hospitalisation, A&E, ambulatory, drug and…

Highlights from NICE 2018 – Tackling Antimicrobial Resistance Globally and Locally

pH Associates were delighted to meet with current and former clients at the NICE Conference #NICEConf18 last week and to have the opportunity to attend some thought-provoking breakout sessions.  Of particular interest was a topical session focused on ‘Tackling Antimicrobial Resistance Globally and Locally’, with Nick Crabb (Programme Director, Scientific Affairs, NICE), Susan Hopkins (Chair…

pH Associates and OPEN Access Consulting will see you at NICE 2018

Amanda Pulfer, MD, pH Associates Dorinda Hickey, CEO, OPEN Access Consulting On Tuesday 26th May The National Institute for Health and Care Excellence (NICE) will host their conference at the Hilton Deansgate Hotel Manchester. The conference will bring together representatives from health, social care and industry to discuss the big challenges facing the health and care…

The rise of digital health and its implications for healthcare and real world evidence

Despite being one of the largest and most rapidly growing sectors in the world, the healthcare industry has generally stuck stringently to a reactive, treatment-focused model. However, with many services close to breaking point, and power shifting rapidly towards technology and the patient themselves, there is heightening pressure on the industry to capitalise on other…